Literature DB >> 18504143

Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men.

Eric W Nawar1, Stephen R Cole, Homayoon Farzadegan, Mallory D Witt, Frank J Jenkins, Joseph B Margolick, John P Phair, Lisa P Jacobson.   

Abstract

PURPOSE: There is notable heterogeneity in the progression to Kaposi's sarcoma (KS) among men coinfected with HIV-1 and human herpesvirus type 8 (HHV-8); additional determinants of KS likely exist. Here, we explore sexual activity as a proxy for a sexually transmitted determinant beyond HIV-1 and HHV-8.
METHODS: The association between sexual activity and incident KS was estimated with data from 1354 HIV-1- and HHV-8-coinfected homosexual men who were followed for up to 10 years in the Multicenter AIDS Cohort Study.
RESULTS: As expected, white race, low CD4 cell count, and the acquisition of HHV-8 after HIV-1 infection increased, whereas smoking decreased, the hazard of KS. The unadjusted hazard of KS among those with high sexual activity was 0.68 relative to the hazard of those with low sexual activity (95% confidence interval, 0.49-0.93) and was somewhat muted after adjustment for characteristics measured at study entry (i.e., race, smoking, CD4 cell count, infection order, history of sexual activity, and sexually transmitted diseases). However, adjustment for time-varying covariates, particularly CD4 cell count, resulted in a nullification of the association (adjusted hazard ratio = 1.06; 95% confidence interval, 0.77-1.48).
CONCLUSION: Once HIV-1 and HHV-8 coinfection is established in homosexual men, progression to KS does not appear to be caused by a third pathogen transmitted by sexual activity.

Entities:  

Mesh:

Year:  2008        PMID: 18504143      PMCID: PMC2587441          DOI: 10.1016/j.annepidem.2008.03.009

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  30 in total

1.  Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.

Authors:  L P Jacobson; F J Jenkins; G Springer; A Muñoz; K V Shah; J Phair; Z Zhang; H Armenian
Journal:  J Infect Dis       Date:  2000-05-26       Impact factor: 5.226

Review 2.  Racial and ethnic disparities in health: an emergency medicine perspective.

Authors:  Janice C Blanchard; Yolanda C Haywood; Carol Scott
Journal:  Acad Emerg Med       Date:  2003-11       Impact factor: 3.451

Review 3.  HHV-8 infection in the transplantation setting: a concern only for solid organ transplant patients?

Authors:  Mario Luppi; Patrizia Barozzi; Valeria Rasini; Giuseppe Torelli
Journal:  Leuk Lymphoma       Date:  2002-03

4.  Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma.

Authors:  T R O'Brien; D Kedes; D Ganem; D R Macrae; P S Rosenberg; J Molden; J J Goedert
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

5.  Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population.

Authors:  S Plancoulaine; L Abel; M van Beveren; D A Trégouët; M Joubert; P Tortevoye; G de Thé; A Gessain
Journal:  Lancet       Date:  2000-09-23       Impact factor: 79.321

6.  Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain.

Authors:  Sílvia de Sanjosé; Vickie Marshall; Judit Solà; Virgilio Palacio; Rosa Almirall; James J Goedert; F Xavier Bosch; Denise Whitby
Journal:  Int J Cancer       Date:  2002-03-01       Impact factor: 7.396

7.  Seropositivity to human herpesvirus 8 in relation to sexual history and risk of sexually transmitted infections among women.

Authors:  R Tedeschi; L Caggiari; I Silins; I Kallings; A Andersson-Ellström; P De Paoli; J Dillner
Journal:  Int J Cancer       Date:  2000-07-15       Impact factor: 7.396

8.  Risk factors for classical Kaposi's sarcoma.

Authors:  James J Goedert; Francesco Vitale; Carmela Lauria; Diego Serraino; Mario Tamburini; Maurizio Montella; Angelo Messina; Elizabeth E Brown; Giovanni Rezza; Lorenzo Gafà; Nino Romano
Journal:  J Natl Cancer Inst       Date:  2002-11-20       Impact factor: 13.506

9.  Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus.

Authors:  Michael J Cannon; Sheila C Dollard; Jodi B Black; Brian R Edlin; Connie Hannah; Susan E Hogan; Mitesh M Patel; Harold W Jaffe; Margaret K Offermann; Thomas J Spira; Philip E Pellett; Clifford J Gunthel
Journal:  AIDS       Date:  2003-01-24       Impact factor: 4.177

10.  Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not.

Authors:  E Byrd Quinlivan; Chuan Zhang; Paul W Stewart; Chulaluk Komoltri; Michelle G Davis; Robert S Wehbie
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

View more
  2 in total

1.  Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus infection in a sample of men who have sex with men in Eastern China.

Authors:  T Zhang; H Lin; V Minhas; W Zhu; C Wood; N He
Journal:  Epidemiol Infect       Date:  2012-10-31       Impact factor: 4.434

2.  Seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus among HIV-negative people in China.

Authors:  Tiejun Zhang; Zhenqiu Liu; Jun Wang; Veenu Minhas; Charles Wood; Gary M Clifford; Na He; Silvia Franceschi
Journal:  Infect Agent Cancer       Date:  2017-05-30       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.